| Literature DB >> 30773277 |
Lindsay C Burrage1, John J Reynolds2, Nissan Vida Baratang3, Jennifer B Phillips4, Jeremy Wegner4, Ashley McFarquhar3, Martin R Higgs2, Audrey E Christiansen5, Denise G Lanza6, John R Seavitt6, Mahim Jain7, Xiaohui Li6, David A Parry8, Vandana Raman9, David Chitayat10, Ivan K Chinn11, Alison A Bertuch6, Lefkothea Karaviti12, Alan E Schlesinger13, Dawn Earl14, Michael Bamshad15, Ravi Savarirayan16, Harsha Doddapaneni17, Donna Muzny17, Shalini N Jhangiani17, Christine M Eng18, Richard A Gibbs19, Weimin Bi18, Lisa Emrick20, Jill A Rosenfeld6, John Postlethwait4, Monte Westerfield4, Mary E Dickinson21, Arthur L Beaudet6, Emmanuelle Ranza22, Celine Huber23, Valérie Cormier-Daire23, Wei Shen24, Rong Mao24, Jason D Heaney6, Jordan S Orange25, Débora Bertola26, Guilherme L Yamamoto26, Wagner A R Baratela27, Merlin G Butler28, Asim Ali29, Mehdi Adeli30, Daniel H Cohn31, Deborah Krakow32, Andrew P Jackson33, Melissa Lees34, Amaka C Offiah35, Colleen M Carlston24, John C Carey36, Grant S Stewart2, Carlos A Bacino1, Philippe M Campeau3, Brendan Lee37.
Abstract
SPONASTRIME dysplasia is an autosomal-recessive spondyloepimetaphyseal dysplasia characterized by spine (spondylar) abnormalities, midface hypoplasia with a depressed nasal bridge, metaphyseal striations, and disproportionate short stature. Scoliosis, coxa vara, childhood cataracts, short dental roots, and hypogammaglobulinemia have also been reported in this disorder. Although an autosomal-recessive inheritance pattern has been hypothesized, pathogenic variants in a specific gene have not been discovered in individuals with SPONASTRIME dysplasia. Here, we identified bi-allelic variants in TONSL, which encodes the Tonsoku-like DNA repair protein, in nine subjects (from eight families) with SPONASTRIME dysplasia, and four subjects (from three families) with short stature of varied severity and spondylometaphyseal dysplasia with or without immunologic and hematologic abnormalities, but no definitive metaphyseal striations at diagnosis. The finding of early embryonic lethality in a Tonsl-/- murine model and the discovery of reduced length, spinal abnormalities, reduced numbers of neutrophils, and early lethality in a tonsl-/- zebrafish model both support the hypomorphic nature of the identified TONSL variants. Moreover, functional studies revealed increased amounts of spontaneous replication fork stalling and chromosomal aberrations, as well as fewer camptothecin (CPT)-induced RAD51 foci in subject-derived cell lines. Importantly, these cellular defects were rescued upon re-expression of wild-type (WT) TONSL; this rescue is consistent with the hypothesis that hypomorphic TONSL variants are pathogenic. Overall, our studies in humans, mice, zebrafish, and subject-derived cell lines confirm that pathogenic variants in TONSL impair DNA replication and homologous recombination-dependent repair processes, and they lead to a spectrum of skeletal dysplasia phenotypes with numerous extra-skeletal manifestations.Entities:
Keywords: DNA repair; DNA replication; SPONASTRIME dysplasia; TONSL; exome sequencing; skeletal dysplasia
Mesh:
Substances:
Year: 2019 PMID: 30773277 PMCID: PMC6408318 DOI: 10.1016/j.ajhg.2019.01.007
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025